RenovoRx (RNXT)

Data from SEC filings
Employee count
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On June 9, 2022, RenovoRx, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on two proposals, each of which is described in more detail in the definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 29, 2022. The matters voted upon at the Annual Meeting and the final voting results for each proposal are set forth below.

Proposal 1: Election of Directors

Name of DirectorForWithheldBroker Non-Votes
Ramtin Agah, M.D.5,399,17940,9641,358,115
Shaun R. Bagai5,400,26939,8741,358,115
David Diamond5,418,00922,1341,358,115
Kirsten Angela Macfarlane5,373,75666,3871,358,115
Laurence J. Marton, M.D.5,373,59466,5491,358,115
Una S. Ryan, O.B.E., Ph.D., D.Sc.5,373,61366,5301,358,115

Each director nominee was duly elected to serve until the 2023 Annual Meeting of Stockholders and until their successor is duly elected and qualified, subject to their earlier resignation or removal.

Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm

ForAgainstAbstainBroker Non-Votes

The stockholders ratified the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.